{"DataElement":{"publicId":"3190746","version":"1","preferredName":"Intravenous tPA Thrombolytic Therapy Initiated at Hospital Time","preferredDefinition":"The time of the day of  start use of infusions of fibrinolytic agents within a blood vessel to destroy or dissolve thrombi in blood vessels or bypass grafts.","longName":"IV_TPA_INIAT_HSP_TM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3190728","version":"1","preferredName":"Intravenous tPA Thrombolytic Therapy Initiation At Hospital Tissue Plasminogen Activator","preferredDefinition":"Intravenous tPA thrombolytic therapy at hospital initiation.","longName":"IV_TPA_INIAT_HSP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3236001","version":"1","preferredName":"Intravenous Tissue Plasminogen Activator Thrombolytic Therapy","preferredDefinition":"(in-tra-VEE-nus) IV. Within a blood vessel.:Tissue plasminogen activator (PLAT) is a serine protease that activates the proenzyme plasminogen to plasmin, which in turn is responsible for fibrinolytic activity. PLAT is synthesized in vascular endothelial cells as a single polypeptide chain. Proteolytic cleavage of the single chain protein at a centrally located arginine-isoleucine bond by plasmin gives rise to a 2-chain disulfide-linked form, composed of the N-terminally derived heavy chain and the C-terminal light chain.:Use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or bypass grafts.","longName":"C13346:C16995:C15338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous","conceptCode":"C13346","definition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tissue-Type Plasminogen Activator","conceptCode":"C16995","definition":"Tissue-type plasminogen activator (562 aa, ~63 kDa) is encoded by the human PLAT gene. This protein plays a role in the cleavage of plasminogen between Arg-580 and Val-581 to form the fibrinolytic enzyme plasmin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thrombolytic Therapy","conceptCode":"C15338","definition":"Any pharmacologic intervention used to destroy or dissolve a clot in a blood vessel or graft.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3A71900-375A-C936-E040-BB89AD4334E4","latestVersionIndicator":"Yes","beginDate":"2011-05-19","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-19","modifiedBy":"ONEDATA","dateModified":"2011-05-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3190751","version":"1","preferredName":"At Hospital Initiation","preferredDefinition":"Used to indicate position, location, or state (American Heritage Dictionary):An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.:The act of starting something; an act that sets in motion some course of events.","longName":"C25427:C16696:C47938","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"At","conceptCode":"C25427","definition":"Used to indicate position, location, or state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hospital","conceptCode":"C16696","definition":"An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Initiation","conceptCode":"C47938","definition":"The act of starting something; an act that sets in motion some course of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BF17170-8C25-D743-E040-BB89AD4336AB","latestVersionIndicator":"Yes","beginDate":"2011-02-10","endDate":null,"createdBy":"LUY","dateCreated":"2011-02-10","modifiedBy":"ONEDATA","dateModified":"2011-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BF0B208-7213-89F6-E040-BB89AD4358E1","latestVersionIndicator":"Yes","beginDate":"2011-02-10","endDate":null,"createdBy":"LUY","dateCreated":"2011-02-10","modifiedBy":"TSESU","dateModified":"2018-05-25","changeDescription":"5/25/18 - smt CDE transferred to NCIP ownership per NINDS (Muniza Sheikh) request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2017049","version":"3","preferredName":"Time","preferredDefinition":"The continuum of experience in which events pass from the future through the present to the past.","longName":"TIME","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"TIME","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"format":"TIME (HR(24):MN)","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193249","version":"1","preferredName":"Time","preferredDefinition":"Time is the continuum of experience in which events pass from the future through the present to the past.  It may also refer to a specific point in this continuum or to the interval separating two points.  It is generally measured in minutes, days, months, or years.","longName":"C25207","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-F1B5-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A56E8150-8EAA-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6272292","version":"1","longName":"NINDS","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000330","version":"1","longName":"Treatment/Intervention Data","context":"NCIP"},{"publicId":"3151265","version":"1","longName":"Drugs","context":"NCIP"},{"publicId":"3188341","version":"1","longName":"Thrombolytic/Reperfusion Therapies","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Time tPA initiated","type":"Preferred Question Text","description":"Time tPA initiated","url":null,"context":"NCIP"},{"name":"NINDS CDE Project","type":"REFERENCE","description":"NINDS CDE Project","url":"http://www.commondataelements.ninds.nih.gov/","context":"NCIP"}],"origin":"NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BF17170-8BE2-D743-E040-BB89AD4336AB","latestVersionIndicator":"Yes","beginDate":"2011-02-10","endDate":null,"createdBy":"LUY","dateCreated":"2011-02-10","modifiedBy":"SBR","dateModified":"2018-12-20","changeDescription":"5/24/18 - smt CDE transferred to NCIP ownership per NINDS (Muniza Sheikh) request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}